TY  - GEN
AU  - McClung,M R
AU  - Zanchetta,J R
AU  - Racewicz,A
AU  - Roux,C
AU  - Benhamou,C-L
AU  - Man,Z
AU  - Eusebio,R A
AU  - Beary,J F
AU  - Burgio,D E
AU  - Matzkin,E
AU  - Boonen,S
AU  - Delmas,P
TI  - Efficacy and safety of risedronate 150-mg once a month in the treatment of postmenopausal osteoporosis: 2-year data
SN  - 1433-2965
PY  - 2013///0610
KW  - Administration, Oral
KW  - Aged
KW  - Biomarkers
KW  - blood
KW  - Bone Density
KW  - drug effects
KW  - Bone Density Conservation Agents
KW  - administration & dosage
KW  - Double-Blind Method
KW  - Drug Administration Schedule
KW  - Etidronic Acid
KW  - Female
KW  - Femur
KW  - physiopathology
KW  - Humans
KW  - Lumbar Vertebrae
KW  - Middle Aged
KW  - Osteoporosis, Postmenopausal
KW  - drug therapy
KW  - Risedronic Acid
KW  - Treatment Outcome
N1  - Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1007/s00198-012-2056-0
ER  -